Institut Mutualiste Montsouris
Institut Mutualiste Montsouris is a non-profit ESPIC acute care hospital in Paris's 14th arrondissement offering comprehensive medical and surgical specialties, maternity, oncology, and maxillofacial surgery, serving individual patients through the French public healthcare reimbursement system with no balance billing.
- Company typePrivate
- Founded1999
- HeadquartersParis, France
- Headcount251–500
- GTM typeB2C
- OfferingServices
What Institut Mutualiste Montsouris does
Institut Mutualiste Montsouris (IMM) is a non-profit acute care hospital (Établissement de Santé Privé d'Intérêt Collectif, ESPIC) located at 42 boulevard Jourdan in Paris's 14th arrondissement, affiliated with the Mutualité Française network and governed by MFPASS. Founded in 1999, the 251–500 employee facility operates as a single comprehensive care campus open 24/7 with a full emergency department, organized around two clinical pillars: a Surgery Department covering ten subspecialties (cardiac, digestive, gynecological, maxillofacial, bariatric, ophthalmological, orthopedic, thoracic, urological, vascular) and a Medical Specialties Department covering eighteen subspecialties (anesthesiology, cardiology, oncology, dermatology, diabetes care, dialysis, pain management, hepatology, maternity, psychiatry, pulmonology, rheumatology, etc.). Supporting infrastructure includes radiology/imaging, medical and anatomical pathology laboratories, pharmacy, intensive care, and a maternity ward. The hospital also runs specialized named institutes — Institut du Thorax Curie-Montsouris (a joint venture with Institut Curie for thoracic oncology), Institut des Maladies Valvulaires, Institut de la Prostate, Centre de l'Obésité, and a reference center for rare gynecological malformations — alongside a Maxillofacial Surgery Department established as a standalone unit in 2023.
Technologically, IMM operates hybrid operating rooms, robotic surgery capability, interventional radiology, 3D-printed personalized cutting guides for orthognathic surgery, piezoelectric ultrasonic bone cutting instruments, and microsurgical free-flap facial reconstruction. Digital infrastructure includes a Health Data Warehouse operational since 2017, an online admission and pre-registration system, a free patient mobile application (launched 2022), Doctolib integration for online appointment booking, and online bill payment via Payzen. AI capability is presently limited to a single research-stage application: the COROSCAN-IA study for automated anatomical and functional classification of coronary arteries in cardiac CT. Patient experience innovations include virtual reality, medical hypnosis, and musicotherapy for pre-operative anxiety reduction (launched 2023).
Commercially, IMM generates revenue through French social security reimbursements (Sécurité sociale), supplementary private insurance, and patient co-payments. As a Sector 1 ESPIC, it does not practice balance billing (pas de dépassement d'honoraires) for most covered procedures; cosmetic procedures are not reimbursed. A secondary revenue stream comes from clinical research funding, with IMM serving as both sponsor and investigator site across more than 80–100 active trials in partnership with AP-HP, Institut Gustave Roussy, multiple French university hospitals, and pharmaceutical and medtech companies. The hospital is ranked in Newsweek's World's Best Hospitals 2026 and in Le Point's annual ranking, and holds the Haute Autorité de Santé (HAS) "Haute qualité des soins" certification.
Institut Mutualiste Montsouris firmographics
Firmographics- Name
- Institut Mutualiste Montsouris
- Legal name
- Institut Montsouris
- Website
- https://imm.fr
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Institut Mutualiste Montsouris is a non-profit ESPIC acute care hospital in Paris's 14th arrondissement offering comprehensive medical and surgical specialties, maternity, oncology, and maxillofacial surgery, serving individual patients through the French public healthcare reimbursement system with no balance billing.
- Ownership category
- akta.pro rank
Institut Mutualiste Montsouris industry classification
Industry- Product category
- Hospital Healthcare Services
- NAICS
- General Medical and Surgical Hospitals (6221)
- SIC
- Services-General Medical & Surgical Hospitals, Nec (8062)
- akta.pro primary industry
- Ambulatory Specialty Clinics (Multi-Specialty & Single-Specialty) (HLAFABAA)
- akta.pro secondary industry
- Hospital-Based Palliative Care (Inpatient Consult Services) (HLADAHAG)
Keywords
Where Institut Mutualiste Montsouris is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Institut Mutualiste Montsouris business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Healthcare services revenue: IMM operates as an ESPIC (Etablissement de Santé Privé d'Intérêt Collectif) - a non-profit private healthcare facility of collective interest. Revenue is generated through public healthcare insurance reimbursements (Sécurité sociale), supplementary insurance coverage, and patient co-payments. No balance billing (pas de dépassement d'honoraires) for most services.
- Clinical research funding: Government and institutional funding for clinical trials where IMM serves as sponsor or investigator site, from organizations including AP-HP, university hospitals, and pharmaceutical companies
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Standard public hospital rates |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Institut Mutualiste Montsouris product offering
Product offeringCore offering
Institut Mutualiste Montsouris is a non-profit ESPIC general hospital in Paris providing comprehensive multi-specialty inpatient and outpatient medical, surgical, and maternity care across 28 specialties plus dedicated institutes for thoracic, valvular, prostate, and obesity conditions. Services include diagnostic imaging, clinical biology, pharmacy, anatomopathology, dialysis, intensive care, pain management, and an active clinical research program with over 80 ongoing trials, all billed at regulated French public hospital rates with no balance billing.
Product overview
Institut Mutualiste Montsouris (IMM) is a multi-specialty hospital (Établissement de Santé Privé d'Intérêt Collectif - ESPIC) in Paris 14th arrondissement, operating as a single unified healthcare facility rather than a platform architecture. The hospital is organized around two core clinical pillars — a Surgery Department (covering 10 subspecialties: cardiac, digestive, gynecological, maxillofacial, bariatric, ophthalmological, orthopedic, thoracic, urological, and vascular surgery) and a Medical Specialties Department (covering 18 subspecialties including cardiology, oncology, anesthesiology, dialysis, pain management, hepatology, maternity, psychiatry, pulmonology, and rheumatology). These are supported by diagnostic and therapeutic services including Medical Imaging/Radiology, Medical Laboratory, Pharmacy, and Anatomopathology. IMM also operates several named institutes and centers: the Institut du Thorax Curie-Montsouris (joint with Institut Curie for thoracic oncology), Institut des Maladies Valvulaires (heart valve diseases), Institut de la Prostate, Centre de l'Obésité, Centre de Référence des Malformations Gynécologiques Rares, Centre de Prévention Cardio-Vasculaire, and a dedicated Maxillofacial Surgery Department (Institut Maxillo-Facial de Paris). The hospital's digital services include an Online Admission System, Online Payment via Payzen, an Ambulatory Care program, a Health Data Warehouse (Entrepôt de Données de Santé), and an active Clinical Research program with over 80 ongoing trials. Additionally, the hospital has introduced patient experience innovations such as virtual reality, medical hypnosis, and musicotherapy for pre-operative anxiety reduction.
Differentiator
Problem solved
Functional benefit
Brands
- Institut du Thorax Curie-Montsouris: Specialized institute for thoracic conditions in partnership with Institut Curie
- Institut des Maladies Valvulaires
- Institut de la Prostate
- Centre de l'obésité
- Centre de référence des malformations gynécologiques rares
Products and services
- Surgery Department Comprehensive surgical department covering 10 subspecialties at IMM: cardiac, digestive, gynecological, maxillofacial, bariatric, ophthalmological, orthopedic, thoracic, urological, and vascular surgery.
- Medical Specialties Department Internal medicine department with 18 subspecialties including anesthesiology, cardiology, oncology, dermatology, diabetes care, dialysis, pain management, hepatology, maternity, psychiatry, pulmonology, and rheumatology.
- Maternity Services Full-service maternity ward in Paris 14th arrondissement offering obstetrics, anesthesia, obstetric ultrasound, smoking cessation, and acupuncture services for expectant mothers.
- Assisted Reproductive Medicine (PMA/AMP) Medically assisted reproduction services including in-vitro fertilization, with dedicated medical team and laboratory.
- Medical Imaging and Radiology Full-service diagnostic and interventional radiology department serving all hospital departments.
- Medical Laboratory Clinical biology laboratory providing diagnostic testing services across all hospital departments.
- Institut du Thorax Curie-Montsouris Specialized institute jointly operated with Institut Curie, focused on thoracic oncology, lung cancer, and chest disease diagnosis and treatment.
- Institut des Maladies Valvulaires Specialized institute dedicated to the diagnosis and treatment of heart valve diseases.
- Institut de la Prostate Dedicated prostate disease institute offering comprehensive diagnostic and treatment services for prostate conditions.
- Centre de l'Obésité (Obesity Center) Multidisciplinary obesity center offering surgical and medical management of obesity, including bariatric surgery.
- Centre de Référence des Malformations Gynécologiques Rares Reference center for rare gynecological malformations, providing specialized surgical care.
- Centre de Prévention Cardio-Vasculaire Cardiovascular prevention center offering screening and preventive care services.
- Maxillofacial Surgery Department Maxillofacial surgery department covering orthognathic surgery, functional rhinoplasty, facial reconstruction, ear reconstruction (otopoiesis), cleft lip/palate sequelae, oral surgery, and dental implants; functions as a referral center for revisional orthognathic surgery.
- Pain Management Services Dedicated department for chronic pain assessment and management across all hospital services.
- Dialysis Services Renal dialysis unit providing hemodialysis services for patients with kidney failure.
- Reanimation and Continuous Care Department Intensive care and continuous monitoring unit for critically ill patients.
- Pharmacy Department Hospital pharmacy providing medication management, dispensing, and clinical pharmacy services.
- Anatomopathology Department Pathology laboratory for tissue analysis and diagnosis, supporting all surgical departments.
Quantifiable outcome
- HAS 'Haute qualité des soins' certification - highest level of healthcare quality certification in France
- +3 more outcomes
Companies that use Institut Mutualiste Montsouris
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
Institut Mutualiste Montsouris technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability6 records
Feature5 records
Institut Mutualiste Montsouris partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- MFPASS (Mutuelle Familiale de Prévoyance et d'Action Sociale)minorParent organization and registered office holder. MFPASS is the mutual benefit organization that operates IMM, providing the institutional framework and healthcare mission. Headquarters located at 3 square Max Hymans, 75748 Paris cedex 15.
- Hôpital Necker-Enfants Malades (AP-HP)coreCollaboration with pediatric hospital for maxillofacial surgery. IMM's maxillofacial surgeons Dr. Julien Davrou and Dr. Nolwenn Lavagen previously trained at Necker, and the collaboration continues for adult patients with congenital conditions previously managed in pediatric settings. Close working relationship with France's leading pediatric center.
- AP-HP (Assistance Publique - Hôpitaux de Paris)coreMajor public hospital system in Paris. IMM participates in numerous clinical trials as investigator site under AP-HP as sponsor. Collaborative research relationship across multiple specialties including anesthesia, cardiac surgery, digestive surgery, hepatology, oncology, and others.
- Institut Gustave RoussyminorFrance's leading cancer center. Collaboration on cancer clinical trials (PROWESs, PRISM-POrTAL, CARE 1) and research programs in oncology.
- CHU de Lille, CHU Dijon, CHU de Rennes, Hospices Civils de Lyon, CHU de Caen, CHU de GrenobleminorVarious French university hospitals collaborating as clinical trial sponsors with IMM as investigation site across cardiology, oncology, digestive surgery, and other specialties.
- Pharmaceutical and medical device companiesminorNumerous pharma and medtech companies (Abbott, Medtronic, Roche, Bristol Myers Squibb, AstraZeneca, Janssen, etc.) partnering as clinical trial sponsors with IMM as investigation site. Relationships governed by standard clinical trial agreements.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Institut Mutualiste Montsouris competitors and assessment
Company assessmentDirect peers
- Institut Gustave Roussy: France's leading cancer center and an active IMM research partner on thoracic and oncology trials (PROWESs, PRISM-POrTAL, CARE 1). Comparable as a leading French specialty institution collaborating with IMM on cancer care delivery and clinical research.
- Groupe Hospitalier Diaconesses Croix Saint-Simon: ESPIC hospital group in Paris operating under the same non-profit collective-interest model as IMM, providing multi-specialty acute care and surgery — comparable in governance, mission and care-mix to IMM.
- Fondation Ophtalmologique Adolphe de Rothschild: ESPIC-status private non-profit hospital in Paris focused on ophthalmology, neurology and head-and-neck specialties. Comparable to IMM as a Paris-based non-profit specialty hospital under the same sector-1 reimbursement regime.
- Hôpital Saint-Joseph (Paris): ESPIC non-profit hospital in Paris offering multi-specialty medical and surgical care with comparable size, mutualist heritage and no-balance-billing model — the closest direct analogue to IMM within the Île-de-France non-profit hospital segment.
- Hôpital Necker-Enfants Malades (AP-HP): AP-HP pediatric hospital and explicit IMM collaboration partner for adult maxillofacial surgery of patients with congenital conditions. Comparable in Paris-based specialty tertiary care and the academic clinical-trial ecosystem IMM participates in.
- Hôpital Foch (Suresnes): ESPIC multi-specialty hospital in the Paris region with a comparable non-profit public-interest status, similar broad surgical/medical offering and academic partnerships; directly comparable to IMM on governance, scale and tariff structure.
Broad incumbents
- Hôpital Pitié-Salpêtrière (AP-HP): Largest AP-HP teaching hospital in Paris with a comprehensive multi-specialty medical and surgical offering. Comparable as a major Île-de-France acute-care competitor and academic research counterparty, but operates on a much larger public-hospital scale.
- Hôpital Européen Georges-Pompidou (AP-HP): AP-HP multi-specialty hospital in Paris with strong cardiac, oncology and surgical programs. Comparable as a large Paris tertiary-care competitor overlapping with IMM's cardiac, oncology and digestive surgery services.
- Hôpital Cochin (AP-HP): AP-HP Paris hospital offering a comparable mix of multi-specialty medicine, surgery and maternity. Competes with IMM for complex referrals and clinical-trial activity in the same metropolitan area.
Regional players
- CHU de Lille: Major French university hospital center that collaborates with IMM as a clinical-trial sponsor across cardiology, oncology and digestive surgery. Comparable as a large French public academic hospital with overlapping research and specialty surgical activity, but based in northern France.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Institut Mutualiste Montsouris social profiles
Digital presenceInstitut Mutualiste Montsouris compliance and trust
Trust signalCompliance4 records
Institut Mutualiste Montsouris financial estimates
Financial estimateRevenue estimate
Valuation estimate
Institut Mutualiste Montsouris leadership team
Management profileNumber of profiles
Profiles1 record
Institut Mutualiste Montsouris funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Institut Mutualiste Montsouris M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Institut Mutualiste Montsouris
What does Institut Mutualiste Montsouris do?
Institut Mutualiste Montsouris is a non-profit ESPIC general hospital in Paris providing comprehensive multi-specialty inpatient and outpatient medical, surgical, and maternity care across 28 specialties plus dedicated institutes for thoracic, valvular, prostate, and obesity conditions. Services include diagnostic imaging, clinical biology, pharmacy, anatomopathology, dialysis, intensive care, pain management, and an active clinical research program with over 80 ongoing trials, all billed at regulated French public hospital rates with no balance billing.
Is Institut Mutualiste Montsouris a public or private company?
Institut Mutualiste Montsouris is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Institut Mutualiste Montsouris founded?
Institut Mutualiste Montsouris was founded in 1999. It employs 251 to 500 people.
Where is Institut Mutualiste Montsouris based?
Institut Mutualiste Montsouris is headquartered in Paris, France, in the Europe region.
How does Institut Mutualiste Montsouris make money?
Two revenue lines are on record. Healthcare services revenue is the primary driver. The others are clinical research funding.
Who are Institut Mutualiste Montsouris's main competitors?
Direct peers on record are Institut Gustave Roussy, Groupe Hospitalier Diaconesses Croix Saint-Simon, Fondation Ophtalmologique Adolphe de Rothschild, Hôpital Saint-Joseph (Paris), Hôpital Necker-Enfants Malades (AP-HP) and Hôpital Foch (Suresnes). Broad incumbents are Hôpital Pitié-Salpêtrière (AP-HP), Hôpital Européen Georges-Pompidou (AP-HP) and Hôpital Cochin (AP-HP). CHU de Lille is listed as a regional player.
Does Institut Mutualiste Montsouris have an API?
No public API is recorded for Institut Mutualiste Montsouris.
What industry is Institut Mutualiste Montsouris in?
Institut Mutualiste Montsouris's product category is Hospital Healthcare Services. Its primary akta.pro industry code is HLAFABAA, Ambulatory Specialty Clinics (Multi-Specialty & Single-Specialty), with a secondary code of HLADAHAG, Hospital-Based Palliative Care (Inpatient Consult Services). Its NAICS code is 6221 and its SIC code is 8062.